Cardiovascular Conference - Evaluation September 12, 2019

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients.	The skills learned in this CME course will be applied in the treatment of my patients. - 5	The skills learned in this CME course will be applied in the treatment of my patients. - 4	The skills learned in this CME course will be applied in the treatment of my patients. - 3	The skills learned in this CME course will be applied in the treatment of my patients. - 2	The skills learned in this CME course will be applied in the treatment of my patients. - 1	The skills learned in this CME course will be applied in the treatment of my patients. - NA

As a result of attending this conference, to what extent do you agree that you will be better able to: (rate the objectives) *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
Identifying patients in need of cardiovascular disease lifestyle modification and preventive pharmacotherapy.	Identifying patients in need of cardiovascular disease lifestyle modification and preventive pharmacotherapy. - 5	Identifying patients in need of cardiovascular disease lifestyle modification and preventive pharmacotherapy. - 4	Identifying patients in need of cardiovascular disease lifestyle modification and preventive pharmacotherapy. - 3	Identifying patients in need of cardiovascular disease lifestyle modification and preventive pharmacotherapy. - 2	Identifying patients in need of cardiovascular disease lifestyle modification and preventive pharmacotherapy. - 1	Identifying patients in need of cardiovascular disease lifestyle modification and preventive pharmacotherapy. - NA
Discuss identifying patients in need of medical prescription for hypertension, diabetes, and hyperlipidemia.	Discuss identifying patients in need of medical prescription for hypertension, diabetes, and hyperlipidemia. - 5	Discuss identifying patients in need of medical prescription for hypertension, diabetes, and hyperlipidemia. - 4	Discuss identifying patients in need of medical prescription for hypertension, diabetes, and hyperlipidemia. - 3	Discuss identifying patients in need of medical prescription for hypertension, diabetes, and hyperlipidemia. - 2	Discuss identifying patients in need of medical prescription for hypertension, diabetes, and hyperlipidemia. - 1	Discuss identifying patients in need of medical prescription for hypertension, diabetes, and hyperlipidemia. - NA
Discuss the need for treatment with aspirin for primary prevention and new data that sheds light on the need to be more conservative than previously.	Discuss the need for treatment with aspirin for primary prevention and new data that sheds light on the need to be more conservative than previously. - 5	Discuss the need for treatment with aspirin for primary prevention and new data that sheds light on the need to be more conservative than previously. - 4	Discuss the need for treatment with aspirin for primary prevention and new data that sheds light on the need to be more conservative than previously. - 3	Discuss the need for treatment with aspirin for primary prevention and new data that sheds light on the need to be more conservative than previously. - 2	Discuss the need for treatment with aspirin for primary prevention and new data that sheds light on the need to be more conservative than previously. - 1	Discuss the need for treatment with aspirin for primary prevention and new data that sheds light on the need to be more conservative than previously. - NA
Apply strategies to reduce the risk of atherosclerotic cardiovascular disease through lipid management for the at-risk patient.	Apply strategies to reduce the risk of atherosclerotic cardiovascular disease through lipid management for the at-risk patient. - 5	Apply strategies to reduce the risk of atherosclerotic cardiovascular disease through lipid management for the at-risk patient. - 4	Apply strategies to reduce the risk of atherosclerotic cardiovascular disease through lipid management for the at-risk patient. - 3	Apply strategies to reduce the risk of atherosclerotic cardiovascular disease through lipid management for the at-risk patient. - 2	Apply strategies to reduce the risk of atherosclerotic cardiovascular disease through lipid management for the at-risk patient. - 1	Apply strategies to reduce the risk of atherosclerotic cardiovascular disease through lipid management for the at-risk patient. - NA

How satisfied or dissatisfied were you with the following conference content? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Lecture materials.	Lecture materials. - 5	Lecture materials. - 4	Lecture materials. - 3	Lecture materials. - 2	Lecture materials. - 1
Speaker's effectiveness in addressing the learning objectives.	Speaker's effectiveness in addressing the learning objectives. - 5	Speaker's effectiveness in addressing the learning objectives. - 4	Speaker's effectiveness in addressing the learning objectives. - 3	Speaker's effectiveness in addressing the learning objectives. - 2	Speaker's effectiveness in addressing the learning objectives. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so?

Please provide any additional comments or suggestions.

Name

You are here

Cardiovascular Conference - Evaluation September 12, 2019